Financial Year |
March 31 2023 |
Monetary Funds |
909,945,351.72 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
107,115,930.28 |
Accounts Receivable |
3,049,334,200.63 |
Advances to Suppliers |
272,894,913.62 |
Other Receivables |
454,880,878.93 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,063,893,974.42 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
5,181,189.52 |
Total Current Assets |
5,951,373,116.81 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
2,577,261,738.21 |
Under-construction Projects |
24,767,406.80 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
200,704,461.80 |
R&D expenses |
-- |
Goodwill |
607,346,640.37 |
Long-Term Deferred and Prepaid Expenses |
93,373,607.76 |
Deferred Income Tax Assets |
62,245,720.59 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
3,938,552,224.99 |
Total Assets |
9,889,925,341.80 |
Short-Term Loans |
1,431,966,273.63 |
Trading Financial liabilities |
-- |
Notes Payable |
238,987,504.41 |
Accounts Payable |
635,764,106.33 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
17,932,520.14 |
Taxes Payable |
31,642,555.60 |
Interest Payable |
-- |
Dividend Payable |
606,957.57 |
Other payables |
332,225,328.26 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,594,976.65 |
Other Current Liabilities |
2,267,949.18 |
Sub-Total of Current Liabilities |
2,723,546,670.36 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
307,906.00 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
39,742,267.62 |
Total Liabilities |
2,763,288,937.98 |
Paid-In Capital(Or Share Stock) |
1,943,851,868.00 |
Capital Surplus |
4,401,764,938.44 |
Surplus Reserve |
89,622,876.19 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
426,156,734.76 |
Minority Stockholder's Interest |
265,239,986.43 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,861,396,417.39 |
Owner's Equity(Stockholder's Equity) |
7,126,636,403.82 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,889,925,341.80 |